• API 99% Oseltamivir CAS 196618-13-0 for Anti-Influenza
  • API 99% Oseltamivir CAS 196618-13-0 for Anti-Influenza
  • API 99% Oseltamivir CAS 196618-13-0 for Anti-Influenza
  • API 99% Oseltamivir CAS 196618-13-0 for Anti-Influenza
  • API 99% Oseltamivir CAS 196618-13-0 for Anti-Influenza
  • API 99% Oseltamivir CAS 196618-13-0 for Anti-Influenza

API 99% Oseltamivir CAS 196618-13-0 for Anti-Influenza

Powder: Yes
Customized: Customized
Certification: GMP, HSE, ISO 9001, USP, BP
Suitable for: Elderly, Children, Adult
State: Solid
Purity: >99%
Samples:
US$ 10/gram 1 gram(Min.Order)
| Request Sample
Customization:
Diamond Member Since 2019

Suppliers with verified business licenses

Rating: 4.9/5

Basic Info.

Model NO.
TGYBIO
Product Name
Oseltamivir
Appearance
White Powder
Test Methods
HPLC
Shelf Life
2 Years
Shipping Methods
DHL, FedEx, TNT and EMS
MOQ
1g
Storage
2 Years
Spe
99%
Transport Package
Foil Bag, Box, Drum
Specification
99%
Trademark
TGY
Origin
China
HS Code
3001200010
Production Capacity
1500kg/Month

Product Description


API 99% Oseltamivir CAS 196618-13-0 for Anti-Influenza
API 99% Oseltamivir CAS 196618-13-0 for Anti-Influenza
Product name:Oseltamivir 
MF:    C16H28N2O4
MW:    312.4
CAS:    196618-13-0
oseltamivir phosphate (oseltamivirphosphate) is a neuraminidase inhibitor anti-influenza drug marketed in 1999 under the trade name Tamiflu(Tamiflu). It was first discovered by GileadSciences, then developed in partnership with Roche and approved for sale in the United States. Oseltamivir phosphate is the first orally effective neuraminidase inhibitor that is effective against both influenza A and B viruses. Oral oseltamivir is rapidly catalyzed by liver and intestinal esterase to its active metabolite, olchemicalbook seltamivir carboxylate. Oseltamivir carboxylate has a configuration similar to the transition state of neuraminic acid and binds competitively to the active site of influenza virus neuraminidase (NA). It is therefore a potent and highly selective influenza virus NA inhibitor (NAIs), which reduces the transmission of influenza A or B viruses mainly by interfering with the release of viruses from infected host cells. Therefore, oseltamivir phosphate is a precursor drug. At present, oseltamivir phosphate (Tamiflu) is still recognized as one of the most effective drugs on the market for the treatment of influenza A (H1N1), which was approved for market in China in July 2004.

API 99% Oseltamivir CAS 196618-13-0 for Anti-Influenza

Oseltamivide phosphate is rapidly metabolized to oseltamivir carboxylate by absorption through the gastrointestinal tract and at least 75 % of the oral dose is involved in systemic circulation in the form of oseltamivircarboxylate
 
The active ingredient Is a potent and unique neuraminidase inhibitor that acts on all aspects of influenza virus infection and prevents the replication of all clinically relevant strains of influenza A or B viruses.

In vitro in very low nanomolarconcentrations that have inhibitory effect. The active metabolite was observed to inhibit the growth of influenza virus in vitro and it was also observed in vivo to inhibit the replication and pathogenicity of influenza virus.

Oseltamivide phosphate reduces the spread of influenza A or B viruses by inhibiting the release of the virus from the infected c
ells.


API 99% Oseltamivir CAS 196618-13-0 for Anti-Influenza

 

 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Diamond Member Since 2019

Suppliers with verified business licenses

Rating: 4.9/5
Terms of Payment
LC, T/T, D/P, PayPal, Western Union, Small-amount payment
International Commercial Terms(Incoterms)
FOB, CFR, CIF, DAT, FAS, DDP, DAP, CIP, CPT, FCA, EXW, Others